Literature DB >> 15463389

Why do some African children develop severe malaria?

B Greenwood1, K Marsh, R Snow.   

Abstract

Malaria is still a major cause of death and severe illness among children in many parts of tropical Africa, but only a small proportion of children, perhaps 1-2%, who become ill with malaria develop severe disease. Why only, some children experience a severe or fatal attack is not understood clearly. In this article, Brian Greenwood, Kevin Marsh and Robert Snow review some of those characteristics of the parasite and the host that may influence the outcome of a malaria infection. Identification of the relative importance of the many factors likely to be involved is needed in order to develop rational strategies for the prevention of deaths from malaria among children in malaria-endemic areas.

Entities:  

Year:  1991        PMID: 15463389     DOI: 10.1016/0169-4758(91)90096-7

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  93 in total

1.  Microsatellite characterization of Plasmodium falciparum from cerebral and uncomplicated malaria patients in southern Vietnam.

Authors:  Marcelo U Ferreira; Shalini Nair; Thien Van Hyunh; Fumihiko Kawamoto; Timothy J C Anderson
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Selection for high and low virulence in the malaria parasite Plasmodium chabaudi.

Authors:  M J Mackinnon; A F Read
Journal:  Proc Biol Sci       Date:  1999-04-07       Impact factor: 5.349

3.  Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.

Authors:  Carlota Dobaño; Diana Quelhas; Llorenç Quintó; Laura Puyol; Elisa Serra-Casas; Alfredo Mayor; Tacilta Nhampossa; Eusebio Macete; Pedro Aide; Inacio Mandomando; Sergi Sanz; Sanjeev K Puniya; Bijender Singh; Puneet Gupta; Arindam Bhattacharya; Virander S Chauhan; John J Aponte; Chetan E Chitnis; Pedro L Alonso; Clara Menéndez
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

4.  Two lessons from the interface of genetics and medicine.

Authors:  Anthony C Allison
Journal:  Genetics       Date:  2004-04       Impact factor: 4.562

Review 5.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar.

Authors:  Arsène Ratsimbasoa; Harintsoa Ravony; Jeanne-Aimée Vonimpaisomihanta; Rogelin Raherinjafy; Martial Jahevitra; Rabenja Rapelanoro; Jean De Dieu Marie Rakotomanga; Denis Malvy; Pascal Millet; Didier Ménard
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

7.  Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans.

Authors:  Louise M Randall; Enny Kenangalem; Daniel A Lampah; Emiliana Tjitra; Esther D Mwaikambo; Tjandra Handojo; Kim A Piera; Zhen Zhen Zhao; Fabian de Labastida Rivera; Yonghong Zhou; Karli M McSweeney; Lien Le; Fiona H Amante; Ashraful Haque; Amanda C Stanley; Tonia Woodberry; Ervi Salwati; Donald L Granger; Maurine R Hobbs; Ric N Price; J Brice Weinberg; Grant W Montgomery; Nicholas M Anstey; Christian R Engwerda
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

8.  Etiologies of autism in a case-series from Tanzania.

Authors:  Raymond E Mankoski; Martha Collins; Noah K Ndosi; Ella H Mgalla; Veronica V Sarwatt; Susan E Folstein
Journal:  J Autism Dev Disord       Date:  2006-11

9.  Allelic polymorphism of MSP2 gene in severe P. falciparum malaria in an area of low and seasonal transmission.

Authors:  Ishraga E A-Elbasit; Gehad ElGhazali; Thoraya M E A-Elgadir; Amel A Hamad; Hamza A Babiker; Mustafa I Elbashir; Hayder A Giha
Journal:  Parasitol Res       Date:  2007-09-04       Impact factor: 2.289

10.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.